Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues

J Med Chem. 1993 Oct 29;36(22):3333-40. doi: 10.1021/jm00074a014.

Abstract

The isolation and structure determination of the naturally occurring LTB4 receptor antagonist Leucettamine A (1) was recently reported. Herein we describe the synthesis of this natural product, the preparation of several analogues, and their effectiveness as antagonists of [3H]LTB4 binding to intact human U-937 cells. Total synthesis of Leucettamine A (1) is achieved by a convergent route which takes advantage of the elements of symmetry within the molecule. Syntheses of analogues of 1, which lacked the same degree of symmetry, are achieved by a different approach starting from alpha-amino acids. The natural product 1 inhibits [3H]LTB4 binding to its receptors on intact human U-937 cells with a Ki = 3.5 +/- 0.8 microM and is devoid of measurable agonist activity at the concentrations tested. 2-Amino imidazole analogues of 1 lacking the dioxolane groups were prepared. Generally these are significantly less potent than 1. However, one (26), designed on the basis of a putative structural overlay with LTB4, demonstrated potency comparable to that of the natural product (Ki = 2.4 +/- 0.2 microM).

MeSH terms

  • Calcium / blood
  • Dioxoles / chemical synthesis*
  • Dioxoles / metabolism
  • Dioxoles / pharmacology*
  • Humans
  • Imidazoles / chemical synthesis*
  • Imidazoles / metabolism
  • Imidazoles / pharmacology*
  • Kinetics
  • Leukotriene B4 / antagonists & inhibitors*
  • Neutrophils / drug effects
  • Neutrophils / metabolism
  • Receptors, Leukotriene B4 / antagonists & inhibitors*
  • Receptors, Leukotriene B4 / metabolism
  • Structure-Activity Relationship

Substances

  • Dioxoles
  • Imidazoles
  • Receptors, Leukotriene B4
  • leucettamine A
  • Leukotriene B4
  • Calcium